Goodwill and Intangible Assets, Net

6 Months Ended

Jun. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill



	Advanced Engineered Materials		Consumer Specialties		Industrial Specialties	Acetyl Intermediates		Total
	(In $ millions)
As of December 31, 2013
Goodwill	303		254		43	198		798
Accumulated impairment losses	—		—		—	—		—
Net book value	303		254		43	198		798
Exchange rate changes	(1	)	(1	)	—	(2	)	(4	)
As of June 30, 2014
Goodwill	302		253		43	196		794
Accumulated impairment losses	—		—		—	—		—
Net book value	302		253		43	196		794

Intangible Assets, Net

Finite-lived intangible assets are as follows:



	Licenses		Customer- Related Intangible Assets		Developed Technology		Covenants Not to Compete and Other		Total
	(In $ millions)
Gross Asset Value
As of December 31, 2013	33		544		30		39		646
Acquisitions	—		—		—		10		10		⁽¹⁾
Exchange rate changes	(1	)	(4	)	—		—		(5	)
As of June 30, 2014	32		540		30		49		651
Accumulated Amortization
As of December 31, 2013	(20	)	(521	)	(21	)	(25	)	(587	)
Amortization	(2	)	(7	)	(1	)	(1	)	(11	)
Exchange rate changes	—		4		—		—		4
As of June 30, 2014	(22	)	(524	)	(22	)	(26	)	(594	)
Net book value	10		16		8		23		57

______________________________


⁽¹⁾	Primarily represents intangible assets acquired related to Fairway with a weighted average amortization period of 27 years (Note 4).

Indefinite-lived intangible assets are as follows:



	Trademarks and Trade Names
	(In $ millions)
As of December 31, 2013	83
Acquisitions	—
Accumulated impairment losses	—
Exchange rate changes	—
As of June 30, 2014	83

The Company's trademarks and trade names have an indefinite life. For the six months ended June 30, 2014, the Company did not renew or extend any intangible assets.

Estimated amortization expense for the succeeding five fiscal years is as follows:



	(In $ millions)
2015	11
2016	8
2017	7
2018	4
2019	3

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details